Directory
>
Gale Smith
Gale Smith
Chief Scientific Officer | Novavax
Maryland, Rockville, United States
Gale Smith
Summary
Gale Smith is a seasoned executive in the biopharmaceutical industry, currently serving as the VP of Vaccine Development at Novavax. With a robust educational background including a PhD in Molecular Biology from Texas A&M University, Gale has dedicated over three decades to advancing vaccine technology and scientific research. Prior to Novavax, Gale held the position of Chief Scientific Officer at Protein Sciences Corporation, where significant contributions were made in vaccine innovation. Gale's leadership is characterized by a commitment to scientific excellence and a deep understanding of the complexities of vaccine development. Known for fostering collaborative environments, Gale is passionate about mentoring the next generation of scientists. Outside of work, Gale enjoys engaging with emerging technologies and sustainability practices within the healthcare sector. With a career spanning multiple leadership roles, Gale embodies the spirit of innovation and resilience in the face of global health challenges.
Gale Smith
Work Experience
Sr VP Vaccine Development and Chief Scient at
Novavax
January 2005 - Present
Gale Smith
Education
Baylor College of Medicine
January 1982 - January 1983
Texas A&M University, PhD, Molecular Biology
January 1982 - January 1986
University of North Dakota, BS, Biology
January 1972
Frequently Asked Questions about Gale Smith
What is Gale Smith email address?
Gale Smith's primary email address is ******@novavax.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Gale Smith work for?
Gale Smith is a Chief Scientific Officer at Novavax.
Where Gale Smith graduated from?
Gale Smith holds a degree in null from Baylor College of Medicine.
How can I directly contact Gale Smith?
To contact Gale Smith directly, you can use the email address ******@novavax.com. Complete contact information is available upon registration with Muraena.
Who is Gale Smith?
Gale Smith is a seasoned executive in the biopharmaceutical industry, currently serving as the VP of Vaccine Development at Novavax. With a robust educational background including a PhD in Molecular Biology from Texas A&M University, Gale has dedicated over three decades to advancing vaccine technology and scientific research. Prior to Novavax, Gale held the position of Chief Scientific Officer at Protein Sciences Corporation, where significant contributions were made in vaccine innovation. Gale's leadership is characterized by a commitment to scientific excellence and a deep understanding of the complexities of vaccine development. Known for fostering collaborative environments, Gale is passionate about mentoring the next generation of scientists. Outside of work, Gale enjoys engaging with emerging technologies and sustainability practices within the healthcare sector. With a career spanning multiple leadership roles, Gale embodies the spirit of innovation and resilience in the face of global health challenges.
Gale`s contact details
******@novavax.com
Colleagues
Business Analyst
Associate Director, Health Care Member Services
Professor of Pediatrics and Microbiology
Vice President and Head of Worldwide Regulatory Affairs Vaccine development
PRISM Product Development and Support
Pediatric Resident
Staffing Account Manager
Principal Scientist
Systems Analyst